ROYCE & ASSOCIATES LP - VIVOS THERAPEUTICS INC ownership

VIVOS THERAPEUTICS INC's ticker is VVOS and the CUSIP is 92859E108. A total of 11 filers reported holding VIVOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of VIVOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$1,723,000
-25.4%
348,0000.0%0.01%
-25.0%
Q1 2021$2,311,000
+30.3%
348,000
+16.0%
0.02%
+6.7%
Q4 2020$1,773,000300,0000.02%
Other shareholders
VIVOS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Strategic Wealth Investment Group, LLC 3,219,705$618,5050.11%
PERKINS CAPITAL MANAGEMENT INC 15,000$30.00%
Apexium Financial, LP 40,667$7,8120.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 213$410.00%
GEODE CAPITAL MANAGEMENT, LLC 201,941$38,7920.00%
STATE STREET CORP 45,650$8,7690.00%
MORGAN STANLEY 1,667$3200.00%
BlackRock Inc. 1,037$1990.00%
LPL Financial LLC 35,484$6,8160.00%
View complete list of VIVOS THERAPEUTICS INC shareholders